Published in Virology on April 20, 1995
Expression of mouse interleukin-4 by a recombinant ectromelia virus suppresses cytolytic lymphocyte responses and overcomes genetic resistance to mousepox. J Virol (2001) 4.98
CD4-deficient mice have reduced levels of memory cytotoxic T lymphocytes after immunization and show diminished resistance to subsequent virus challenge. J Virol (1996) 3.39
The vaccinia virus soluble alpha/beta interferon (IFN) receptor binds to the cell surface and protects cells from the antiviral effects of IFN. J Virol (2000) 2.08
Natural pathogens of laboratory mice, rats, and rabbits and their effects on research. Clin Microbiol Rev (1998) 1.88
Polarized type 1 cytokine response and cell-mediated immunity determine genetic resistance to mousepox. Proc Natl Acad Sci U S A (2004) 1.56
Poxvirus immunomodulatory strategies: current perspectives. J Virol (2003) 1.52
IL-18 binding and inhibition of interferon gamma induction by human poxvirus-encoded proteins. Proc Natl Acad Sci U S A (1999) 1.42
A mechanism for the inhibition of fever by a virus. Proc Natl Acad Sci U S A (1996) 1.39
Vaccinia virus interleukin-18-binding protein promotes virulence by reducing gamma interferon production and natural killer and T-cell activity. J Virol (2003) 1.34
Interferon function is not required for recovery from a secondary poxvirus infection. Proc Natl Acad Sci U S A (2005) 1.21
Vaccinia virus vectors with an inactivated gamma interferon receptor homolog gene (B8R) are attenuated In vivo without a concomitant reduction in immunogenicity. J Virol (2001) 1.21
Expression of secreted cytokine and chemokine inhibitors by ectromelia virus. J Virol (2000) 1.20
Steroid hormone synthesis by vaccinia virus suppresses the inflammatory response to infection. J Exp Med (2003) 1.19
Inhibition of interferons by ectromelia virus. J Virol (2002) 1.15
A mouse model of lethal infection for evaluating prophylactics and therapeutics against Monkeypox virus. J Virol (2010) 1.12
Inhibition of type I and type III interferons by a secreted glycoprotein from Yaba-like disease virus. Proc Natl Acad Sci U S A (2007) 1.08
The immunologic aspects of poxvirus oncolytic therapy. Cancer Immunol Immunother (2009) 1.06
Induction of potent humoral and cell-mediated immune responses by attenuated vaccinia virus vectors with deleted serpin genes. J Virol (2004) 1.06
Inhibition of type 1 cytokine-mediated inflammation by a soluble CD30 homologue encoded by ectromelia (mousepox) virus. J Exp Med (2002) 1.05
Lethal monkeypox virus infection of CAST/EiJ mice is associated with a deficient gamma interferon response. J Virol (2012) 1.00
Removal of vaccinia virus genes that block interferon type I and II pathways improves adaptive and memory responses of the HIV/AIDS vaccine candidate NYVAC-C in mice. J Virol (2012) 0.98
Subversion of cytokine networks by virally encoded decoy receptors. Immunol Rev (2012) 0.98
Stunned silence: gene expression programs in human cells infected with monkeypox or vaccinia virus. PLoS One (2011) 0.98
Poxvirus-encoded gamma interferon binding protein dampens the host immune response to infection. J Virol (2007) 0.97
M135R is a novel cell surface virulence factor of myxoma virus. J Virol (2006) 0.94
Role of genes that modulate host immune responses in the immunogenicity and pathogenicity of vaccinia virus. J Virol (2005) 0.92
Systemic delivery of oncolytic viruses: hopes and hurdles. Adv Virol (2012) 0.90
CD8 T cells use IFN-γ to protect against the lethal effects of a respiratory poxvirus infection. J Immunol (2014) 0.90
Vaccinia virus protein N2 is a nuclear IRF3 inhibitor that promotes virulence. J Gen Virol (2013) 0.90
Structure and mechanism of IFN-gamma antagonism by an orthopoxvirus IFN-gamma-binding protein. Proc Natl Acad Sci U S A (2008) 0.90
Analysis of an orf virus chemokine-binding protein: Shifting ligand specificities among a family of poxvirus viroceptors. Proc Natl Acad Sci U S A (2003) 0.89
A mechanism for the inhibition of DNA-PK-mediated DNA sensing by a virus. PLoS Pathog (2013) 0.88
Vaccinia virus infection of mature dendritic cells results in activation of virus-specific naïve CD8+ T cells: a potential mechanism for direct presentation. Virology (2006) 0.88
Vaccinia virus protein K7 is a virulence factor that alters the acute immune response to infection. J Gen Virol (2013) 0.86
Replication-Competent Viruses as Cancer Immunotherapeutics: Emerging Clinical Data. Hum Gene Ther (2015) 0.83
Orthopoxvirus genes that mediate disease virulence and host tropism. Adv Virol (2012) 0.83
Myxoma virus Serp2 is a weak inhibitor of granzyme B and interleukin-1beta-converting enzyme in vitro and unlike CrmA cannot block apoptosis in cowpox virus-infected cells. J Virol (1999) 0.83
The unique C termini of orthopoxvirus gamma interferon binding proteins are essential for ligand binding. J Virol (2006) 0.83
Protective effect of exogenous recombinant mouse interferon-gamma and tumour necrosis factor-alpha on ectromelia virus infection in susceptible BALB/c mice. Clin Exp Immunol (2004) 0.81
Genetic variability of immunomodulatory genes in ectromelia virus isolates detected by denaturing high-performance liquid chromatography. J Virol (2003) 0.78
Use of a recombinant vaccinia virus expressing interferon gamma for post-exposure protection against vaccinia and ectromelia viruses. PLoS One (2013) 0.77
Mechanisms of immunomodulation by mammalian and viral decoy receptors: insights from structures. Nat Rev Immunol (2016) 0.76
Fas/FasL pathway participates in regulation of antiviral and inflammatory response during mousepox infection of lungs. Mediators Inflamm (2015) 0.76
Attenuation of Vaccinia Virus. Acta Naturae (2016) 0.75
Inhibition of viral replication by interferon-gamma-induced nitric oxide synthase. Science (1993) 4.80
Herpes simplex virus types 1 and 2 completely help adenovirus-associated virus replication. J Virol (1981) 3.72
Membrane depolarization and calcium induce c-fos transcription via phosphorylation of transcription factor CREB. Neuron (1990) 3.70
Decreased virulence of recombinant vaccinia virus expression vectors is associated with a thymidine kinase-negative phenotype. Nature (1985) 3.62
Plasma concentrations after oral or intramuscular vitamin K1 in neonates. Arch Dis Child (1985) 2.69
Helminth infection results in decreased virus-specific CD8+ cytotoxic T-cell and Th1 cytokine responses as well as delayed virus clearance. Proc Natl Acad Sci U S A (1993) 2.65
Induction of cytotoxic T-cell responses in vivo in the absence of CD4 helper cells. Nature (1987) 2.45
The complete DNA sequence of myxoma virus. Virology (1999) 2.44
Characterization of adenovirus-associated virus-induced polypeptides in KB cells. J Virol (1978) 2.40
Calcium and growth factor pathways of c-fos transcriptional activation require distinct upstream regulatory sequences. Mol Cell Biol (1988) 2.40
Different roles for CD4+ and CD8+ T lymphocytes and macrophage subsets in the control of a generalized virus infection. J Virol (1996) 2.32
Vaccinia virus B18R gene encodes a type I interferon-binding protein that blocks interferon alpha transmembrane signaling. J Biol Chem (1995) 2.27
Vaccinia and cowpox viruses encode a novel secreted interleukin-1-binding protein. Cell (1992) 2.19
A new family of lipolytic enzymes? Trends Biochem Sci (1995) 2.17
Importance of interferons in recovery from mousepox. J Virol (1993) 2.12
Biogenesis of vaccinia: isolation of conditional lethal mutants and electron microscopic characterization of their phenotypically expressed defects. Virology (1978) 2.09
Encoding of a homolog of the IFN-gamma receptor by myxoma virus. Science (1992) 2.07
CD4+ T cells are required for development of a murine retrovirus-induced immunodeficiency syndrome (MAIDS). J Exp Med (1988) 2.06
Identification of a gammaherpesvirus selective chemokine binding protein that inhibits chemokine action. J Virol (2000) 1.86
Virus-encoded serine proteinase inhibitor SERP-1 inhibits atherosclerotic plaque development after balloon angioplasty. Circulation (1996) 1.86
Modulating chemokines: more lessons from viruses. Immunol Today (2000) 1.85
Apoptosis: an innate immune response to virus infection. Trends Microbiol (1999) 1.82
Gamma interferon-induced, nitric oxide-mediated inhibition of vaccinia virus replication. J Virol (1995) 1.74
The complete genome sequence of shope (rabbit) fibroma virus. Virology (1999) 1.73
The T1/35kDa family of poxvirus-secreted proteins bind chemokines and modulate leukocyte influx into virus-infected tissues. Virology (1997) 1.72
Abrogation of resistance to severe mousepox in C57BL/6 mice infected with LP-BM5 murine leukemia viruses. J Virol (1987) 1.72
Sequence-nonspecific replication of transfected plasmid DNA in poxvirus-infected cells. Proc Natl Acad Sci U S A (1986) 1.71
T2 open reading frame from the Shope fibroma virus encodes a soluble form of the TNF receptor. Biochem Biophys Res Commun (1991) 1.64
Deletion analysis of two tandemly arranged virulence genes in myxoma virus, M11L and myxoma growth factor. J Virol (1992) 1.59
Gene expression and cytopathic effect of vaccinia virus inactivated by psoralen and long-wave UV light. J Virol (1996) 1.58
Restricted replication of ectromelia virus in cell culture correlates with mutations in virus-encoded host range gene. Virology (1992) 1.56
Emergency asthma inhalers in school. Arch Dis Child (2003) 1.56
Replication and resolution of cloned poxvirus telomeres in vivo generates linear minichromosomes with intact viral hairpin termini. J Virol (1986) 1.53
The site-specific cleavage of synthetic Holliday junction analogs and related branched DNA structures by bacteriophage T7 endonuclease I. J Biol Chem (1987) 1.52
A poxvirus-encoded semaphorin induces cytokine production from monocytes and binds to a novel cellular semaphorin receptor, VESPR. Immunity (1998) 1.52
High levels of genetic recombination among cotransfected plasmid DNAs in poxvirus-infected mammalian cells. J Virol (1988) 1.50
SERP1, a serine proteinase inhibitor encoded by myxoma virus, is a secreted glycoprotein that interferes with inflammation. Virology (1993) 1.49
A poxvirus-encoded uracil DNA glycosylase is essential for virus viability. J Virol (1993) 1.45
Use of chemokine receptors by poxviruses. Science (1999) 1.43
The purified myxoma virus gamma interferon receptor homolog M-T7 interacts with the heparin-binding domains of chemokines. J Virol (1997) 1.43
M11L: a novel mitochondria-localized protein of myxoma virus that blocks apoptosis of infected leukocytes. J Exp Med (2000) 1.39
Genomic cartography of varicella-zoster virus: a complete genome-based analysis of strain variability with implications for attenuation and phenotypic differences. Virology (2006) 1.39
Myxoma virus expresses a secreted protein with homology to the tumor necrosis factor receptor gene family that contributes to viral virulence. Virology (1991) 1.39
Myxoma virus and malignant rabbit fibroma virus encode a serpin-like protein important for virus virulence. Virology (1990) 1.38
Kinetics of ectromelia virus (mousepox) transmission and clinical response in C57BL/6j, BALB/cByj and AKR/J inbred mice. Lab Anim Sci (1985) 1.38
Disruption of M-T5, a novel myxoma virus gene member of poxvirus host range superfamily, results in dramatic attenuation of myxomatosis in infected European rabbits. J Virol (1996) 1.37
A third distinct tumor necrosis factor receptor of orthopoxviruses. Proc Natl Acad Sci U S A (1998) 1.34
Myxoma virus M-T5 protects infected cells from the stress of cell cycle arrest through its interaction with host cell cullin-1. J Virol (2005) 1.33
Biogenesis of poxviruses: mirror-image deletions in vaccinia virus DNA. Cell (1979) 1.30
Potential role of PKR in double-stranded RNA-induced macrophage activation. EMBO J (2000) 1.29
Immunomodulation by viruses: the myxoma virus story. Immunol Rev (1999) 1.28
Differential inhibition of the Fas- and granule-mediated cytolysis pathways by the orthopoxvirus cytokine response modifier A/SPI-2 and SPI-1 protein. Proc Natl Acad Sci U S A (1996) 1.27
Expression of the myxoma virus tumor necrosis factor receptor homologue and M11L genes is required to prevent virus-induced apoptosis in infected rabbit T lymphocytes. Virology (1996) 1.27
Viral Genome DataBase: storing and analyzing genes and proteins from complete viral genomes. Bioinformatics (2000) 1.26
Poxviruses: past, present and future. Virus Res (2006) 1.26
Identification of a poxvirus gene encoding a uracil DNA glycosylase. Proc Natl Acad Sci U S A (1993) 1.25
Mutations in active-site residues of the uracil-DNA glycosylase encoded by vaccinia virus are incompatible with virus viability. J Virol (1996) 1.25
A poxvirus protein that binds to and inactivates IL-18, and inhibits NK cell response. J Immunol (2000) 1.25
Myxoma virus M-T7, a secreted homolog of the interferon-gamma receptor, is a critical virulence factor for the development of myxomatosis in European rabbits. Virology (1996) 1.24
Myxoma virus targets primary human leukemic stem and progenitor cells while sparing normal hematopoietic stem and progenitor cells. Leukemia (2009) 1.22
A new family of lipolytic plant enzymes with members in rice, arabidopsis and maize. FEBS Lett (1995) 1.22
Inhibition of an inflammatory response is mediated by a 38-kDa protein of cowpox virus. Virology (1989) 1.21
Mechanism of replication of phi x174 single-stranded DNA. IX. Requirement for the Escherichia coli dnaG protein. J Virol (1974) 1.21
Generation of an anti-tumour immune response in a non-immunogenic tumour: HSVtk killing in vivo stimulates a mononuclear cell infiltrate and a Th1-like profile of intratumoural cytokine expression. Int J Cancer (1997) 1.20
The genome of Shope fibroma virus, a tumorigenic poxvirus, contains a growth factor gene with sequence similarity to those encoding epidermal growth factor and transforming growth factor alpha. Mol Cell Biol (1987) 1.19
Identification and DNA sequence of the large subunit of the capping enzyme from Shope fibroma virus. Virology (1991) 1.19
A possible screening test for inherited p53-related defects based on the apoptotic response of peripheral blood lymphocytes to DNA damage. Br J Cancer (1995) 1.17
Mapping and sequencing of a gene from myxoma virus that is related to those encoding epidermal growth factor and transforming growth factor alpha. J Virol (1987) 1.16
Physical characterization and molecular cloning of the Shope fibroma virus DNA genome. Virology (1983) 1.16
Tumorigenic poxviruses: analysis of viral DNA sequences implicated in the tumorigenicity of Shope fibroma virus and malignant rabbit virus. Virology (1986) 1.16
Genetic determinants of resistance to ectromelia (mousepox) virus-induced mortality. J Virol (1985) 1.15
Immunomodulatory proteins of myxoma virus. Semin Immunol (2001) 1.14
Reexamination of the efficacy of vaccination against mousepox. Lab Anim Sci (1985) 1.13
A poxvirus protein with a RING zinc finger motif is of crucial importance for virulence. Virology (1994) 1.13
Insertional inactivation of the large subunit of ribonucleotide reductase encoded by vaccinia virus is associated with reduced virulence in vivo. Virology (1990) 1.12
Role of lymphokine-secreting CD8+ T cells in cytotoxic T lymphocyte responses against vaccinia virus. J Immunol (1989) 1.12
Expression of eight unrelated Muc+ plasmids in eleven DNA repair-deficient E. coli strains. Mutat Res (1983) 1.12
The viral anti-inflammatory chemokine-binding protein M-T7 reduces intimal hyperplasia after vascular injury. J Clin Invest (2000) 1.12
Tumorigenic poxviruses: genomic organization and DNA sequence of the telomeric region of the Shope fibroma virus genome. Virology (1987) 1.09
Identification and nucleotide sequence of the thymidine kinase gene of Shope fibroma virus. J Virol (1986) 1.09
Mechanisms of beta-cell death in response to double-stranded (ds) RNA and interferon-gamma: dsRNA-dependent protein kinase apoptosis and nitric oxide-dependent necrosis. Am J Pathol (2001) 1.08
Poxvirus-induced alteration of arachidonate metabolism. Proc Natl Acad Sci U S A (1993) 1.07
Cruciform extrusion in plasmids bearing the replicative intermediate configuration of a poxvirus telomere. J Mol Biol (1987) 1.07
The myxoma virus-soluble interferon-gamma receptor homolog, M-T7, inhibits interferon-gamma in a species-specific manner. J Biol Chem (1995) 1.07
Functional comparisons among members of the poxvirus T1/35kDa family of soluble CC-chemokine inhibitor glycoproteins. Virology (1998) 1.06
Inhibition of plasmin, urokinase, tissue plasminogen activator, and C1S by a myxoma virus serine proteinase inhibitor. J Biol Chem (1993) 1.06
The myxoma virus M-T4 gene encodes a novel RDEL-containing protein that is retained within the endoplasmic reticulum and is important for the productive infection of lymphocytes. Virology (1997) 1.06